Posterior reversible encephalopathy syndrome associated with use of Atezolizumab for the treatment of relapsed triple negative breast cancer

Bartynski, 2008, Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features, Am. J. Neuroradiol., 29 2017, Posterior reversible encephalopathy syndrome, J. Neurol., 264, 1608, 10.1007/s00415-016-8377-8 Fugate, 2015, Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions, L Neurol., 14, 915 Bartynski, 2008, Posterior reversible encephalopathy syndrome after solid organ transplantation, AM J. Neuroradiol., 924, 10.3174/ajnr.A0960 Masetti, 2015, PRES in children undergoing hematopoietic stem cell or solid organ transplantation, Pediatrics, 135, 890, 10.1542/peds.2014-2325 Le, 2014, Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients, Curr. Oncol. Rep., 16, 383, 10.1007/s11912-014-0383-3 Seol, 2017, Reversible posterior leukoencephalopathy syndrome after eribulin mesylate chemotherapy for breast cancer, Breast J., 23, 10.1111/tbj.12776 Harrold, 2019, Palbociclib-induced posterior reversible encephalopathy syndrome: a previously unreported toxicity, J. Oncol. Practice, 15, 119, 10.1200/JOP.18.00643 Chen, 2012, Reversible posterior leukoencephalopathy syndrome induced by vinorelbine, Clin. Breast Cancer, 12, 222, 10.1016/j.clbc.2012.01.006 Singer, 2015, Posterior reversible encephalopathy syndrome in patients with cancer, Oncologist, 20, 806, 10.1634/theoncologist.2014-0149 Abughanimeh, 2018, Trastuzumab-associated posterior reversible encephalopathy syndrome, Cureus, 10 Kim, 2019, Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non–small-cell lung cancer, Clin. Case Rep., 935, 10.1002/ccr3.2122 LaPorte, 2017, Posterior reversible encephalopathy syndrome following pembrolizumab therapy for relapsed hodgkin's lymphoma, J. Oncol. Pharm. Pract., 23, 71, 10.1177/1078155215620922 Hussein, 2017, Nivolumab-induced posterior reversible encephalopathy syndrome, Neurol. Clin. Pract., 7, 455, 10.1212/CPJ.0000000000000362